Abiopharma

🔍 Karnawat Sunil Ratilal (Executive)

Company: Rezolute, Inc. (RZLT)

Report Date: 2025-08-18

Detailed Transactions and Holdings:

• Acquired 25,000 shares of Common Shares (Direct)
  Date: 2025-08-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 27,442.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Shares (Direct)
  Date: 2025-08-18 | Code: H | nature_of_ownership: Held in Imdividual Retirement Account | shares_owned_after: 8,000.00
• Holds 0 shares of Common Shares (Direct)
  Date: 2025-08-18 | Code: H | nature_of_ownership: Held in Heath Savings Account | shares_owned_after: 1,898.00
• Acquired 275,000 shares of Employee Stock Option (Right to Buy) at $6.55 per share (Derivative)
  Date: 2025-08-18 | Code: A | Expires: 2035-08-18 | equity_swap_involved: 0 | shares_owned_after: 275,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents grant of restricted stock units which vest as follows: 1/4 on September 1, 2026; 1/4 on September 1, 2027; 1/4 on September 1, 2028; and 1/4 on September 1, 2029.
• F2: The options shall vest and become exercisable as follows: One fourth (1/4) of such Options shall vest on the one-year anniversary of the grant date and one thirty-sixth (1/36) of the remaining Options shall vest on the same day of each month thereafter until the Option is 100% vested. The unvested portion of the Option will not be exercisable on or after the Reporting Person's termination of continuous service.